JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2010, Vol. 48 ›› Issue (11): 70-.

• Articles • Previous Articles     Next Articles

Effects of sodium butyrate on cell proliferation and expression of ICAM-1 in the HT-29 colon cancer cell line

LI Wan-quan1, ZHU Xiao-lin2, YU Cheng-gong2   

  1. 1. Xinxiang Hongqi Hospital, Xinxiang 453100, Henan, China;  2. Department of Gastroenterology, The Affiliated Drum
    Tower Hospital of Nanjing University  Medical School, Nanjing 210008, China
  • Received:2010-05-15 Online:2010-11-16 Published:2010-11-16

Abstract:

Objective    To investigate the effects of sodium butyrate on HT-29 colon cancer cell proliferation and expression of intercellular adhesion molecule 1 (ICAM-1) on the cell surface, and to explore the mechanism by which sodium butyrate affects growth of HT-29 cells. Methods    Effect of sodium butyrate on the proliferation of HT-29 cells was detected by MTT[1-(4,5-Dimethylthiazol-2yl)-3,5-diphenylformazan] assay. The cell cycle, cell apoptosis and expression of ICAM-1 induced by sodium butyrate were measured by flow cytometry. Results    In a time-and dose-dependent manner, sodium butyrate significantly inhibited the growth of HT29 cells, increased the proportion of G0/G1 cells and the proliferation index, decreased the proportion of S phase cells, and induced cell apoptosis. Also, sodium butyrate down-regulated expression of ICAM-1. Conclusion    Sodium butyrate can inhibit the proliferation of HT-29 cells. The mechanism may relate to arresting the cell cycle, inducing cell apoptosis and down-regulating expression of ICAM-1 on HT-29 cells.

Key words: Sodium butyrate; HT-29; Colon cancer; Intercellular adhesion molecule 1

CLC Number: 

  • R735.3
[1] YUAN Zhi-ping1, MU Hua-ping2, WANG Qiu1, WANG Li-shuai1, CHEN Jie1,ZHANG Chuan-li1, ZHOU Guang-yuan1, CHEN Jia-lian1. VEGF and sICAM-1 protein expressions and their clinical significance in serum of patients with colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(10): 74-76.
[2] Lv Yan-feng1, HAN Bing-bing2, YU Hua-long1, WANG Jian-xin1. Construction and effect of shRNA vector silencing EZH2 expression [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 31-34.
[3] SUN Xiu-mei1, GAO Feng2, LIU Zi-feng3. Inhibition of Salinomycin on the characteristics of colon cancer stem cell [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 40-44.
[4] FENG Fei1, YAN Jin2, YUAN Ping1, HU Xiao-qin1, XU Lin2, YANG Yan-fang1. Relationships between dietary, lifestyle and colorectal cancer: a matched casecontrol study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 107-112.
[5] WANG Bin, LI Zeng-jun, XU Zhong-fa, SUN Yan-lai, GONG Wei-peng,GUO Hong-liang, CHAI Jie, HAN Jian-jun. Impact of the surgery interval after short course preoperative radiotherapy of rectal cancer on perineal wound healing [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 92-95.
[6] REN Peng1, HAO Qing2, WANG Jie-shu3, LI Hong-lin3, LI Bo3, WANG Feng3. Roles of CXC chemokine receptor 3 and vasculogenic mimicry in 
hepatic metastasis of colonic carcinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 96-99.
[7] LI Jing1, YIN Lin-lin1, ZHANG Gang-feng2, WANG Jing3. Prognostic implication of p27 and cyclinD1 in colorectal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 105-.
[8] ZHANG Jiang-zhou1, LU Xiao-kai2, Feng Zhi-yu2, LONG Zhi-xiong1, RAN Li3, TAN Shi-sheng2. Dosimetric evaluation of three techniques in postoperative
radiotherapy  for  gastric  carcinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 64-69.
[9] CHU Qian-qian1, XU Gang2, REN Gui-jie1, XU Xia1, HU Zhong-yi1, LIU Yong-qing1, YUAN Hui-qing1, TIAN Ke-li1. Effect of rosiglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, in sensitizing 5-fluorouracil chemotherapy for colon cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 66-71.
[10] ZHANG Binbin1, CHEN Tiantian2, WANG Guochang2, L Ming3. Comparison of clinicopathological characteristics of rectal  cancer between elderly and young patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 120-.
[11] JIANG Ying-jun1,2, KONG Xin-juan3, ZHANG Ke-shuang3, HU San-yuan1. Expression of c-Met and its role in development and  progression of colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(5): 90-93.
[12] WANG Kai-lei, LI Le-ping, JING Chang-qing. Establishment and comparison of two human multidrug-resistant colorectal carcinoma cell lines [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 75-.
[13] CHI Yuan-wei1, CHEN Jian2, LIU Liang2, WANG Min3, QI Ying-ying2, LIU Jun2. Expressions of hTERT and P53 and significance in colorectal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 115-117.
[14] MA Lan-qing1,GUO Yong-zhang2,ZHANG Hong-bing2,ZHU Zhu2,CHEN Ming-qing3, DUAN Li-ping1. Inhibitory effect of short interfering RNA-mediated gene silencing on expression  of VEGF and cell proliferation in murine colon carcinoma cells  [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(11): 63-69.
[15] KONG Shuai, LI Leping, JING Changqing, WANG Feng. The reversal effect on MDR1 gene-mediated multidrug resistance in human colon carcinoma LoVo/5-Fu cells by RNA interference [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(6): 80-83.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!